SEI Investments
TXG icon

SEI Investments’s 10x Genomics TXG Stock Holding History

SEI Investments’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.02M Buy
52,707
+8,028
+18% +$210K ﹤0.01% 1953
2026
Q1 		$949K Buy
44,679
+23,748
+113% +$475K ﹤0.01% 2376
2025
Q4 		$341K Buy
+20,931
New +$316K ﹤0.01% 2673
2025
Q3 		– Sell
-13,022
Closed -$151K – 2910
2025
Q2 		$151K Sell
13,022
-28,249
-68% -$257K ﹤0.01% 2623
2025
Q1 		$360K Buy
+41,271
New +$520K ﹤0.01% 2265
2024
Q4 		– Sell
-12,423
Closed -$281K – 2799
2024
Q3 		$281K Sell
12,423
-17,326
-58% -$358K ﹤0.01% 2379
2024
Q2 		$579K Sell
29,749
-587
-2% -$15.4K ﹤0.01% 2105
2024
Q1 		$1.14M Sell
30,336
-13,406
-31% -$589K ﹤0.01% 1831
2023
Q4 		$2.45M Sell
43,742
-134
-0.3% -$5.83K ﹤0.01% 1513
2023
Q3 		$1.81M Sell
43,876
-1,973
-4% -$103K ﹤0.01% 1646
2023
Q2 		$2.56M Buy
45,849
+6,569
+17% +$356K ﹤0.01% 1523
2023
Q1 		$2.19M Buy
39,280
+16,478
+72% +$769K ﹤0.01% 1583
2022
Q4 		$831K Buy
22,802
+6,494
+40% +$212K ﹤0.01% 1829
2022
Q3 		$465K Sell
16,308
-14,221
-47% -$542K ﹤0.01% 2123
2022
Q2 		$1.32M Buy
30,529
+1,581
+5% +$82K ﹤0.01% 1720
2022
Q1 		$2.2M Buy
28,948
+8,136
+39% +$712K ﹤0.01% 1506
2021
Q4 		$3.1M Sell
20,812
-2,814
-12% -$431K 0.01% 1378
2021
Q3 		$3.44M Sell
23,626
-33
-0.1% -$5.67K 0.01% 1274
2021
Q2 		$4.63M Buy
23,659
+1,692
+8% +$306K 0.01% 1118
2021
Q1 		$3.98M Buy
21,967
+19,055
+654% +$3.29M 0.01% 1137
2020
Q4 		$412K Buy
+2,912
New +$423K ﹤0.01% 2073

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SEI Investments's TXG Position: Q2 2026 in Review

SEI Investments increased its 10x Genomics (TXG) stake by 18% in Q2 2026, buying an estimated $210K and bringing the position to 52,707 shares worth $2.02M. The position accounts for ﹤0.01% of the portfolio, ranked #1953.

SEI Investments first reported a position in TXG in Q4 2020 and has held it in 21 quarters since. The position peaked at $4.63M in Q2 2021. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • SEI Investments held 52,707 shares of 10x Genomics worth $2.02M as of Q2 2026.
  • SEI Investments bought 8,028 10x Genomics shares in Q2 2026, an estimated $210K.
  • 10x Genomics made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #1953 holding.
  • SEI Investments first reported a position in 10x Genomics in Q4 2020 and has held it in 21 quarters since.
  • SEI Investments's 10x Genomics position peaked at $4.63M in Q2 2021.
  • 390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.